Skip to main content

Table 3 Comparison of characteristics in NTM patients with frail status and robust status

From: Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study

 

NTM patients with frail

NTM patients with robust

P value

n = 16

n = 17

Age

73.2 ± 8.1

62.4 ± 10.7

0.0089

Sex (female)

11 (68.8)

14 (82.4)

0.44

BMI

18.7 ± 2.6

19.4 ± 2.1

0.3

Smoking status

3 (18.8)

1 (5.9)

0.335

Underlying disease

 COPD

1 (6.3)

0 (0.0)

0.485

 History of tuberculosis

0 (0.0)

1 (5.9)

0.99 < 

 History of malignant disease

0 (0.0)

1 (5.9)

0.99 < 

 Autoimmune disease

0 (0.0)

1 (5.9)

0.99 < 

Infected NTM strain

 M. avium

5 (31.3)

10 (58.8)

-

 M. intracellulare

5 (31.3)

4 (23.5)

-

 M. avium + M. intracellulare

1 (6.3)

2 (11.8)

-

 M. abscessus

4 (25.0)

0 (0.0)

-

 Others

1 (6.3)

1 (5.9)

 

HRCT findings

 Nodular-bronchiectatic (NB)

9 (56.3)

15 (88.2)

0.057

 Combined NB + Fibro-cavitary

5 (31.3)

1 (5.9)

0.042

 Unclassifieda

2 (12.5)

1 (5.9)

0.601

Thoracic abnormality

 Scoliosis

6 (37.5)

4 (23.5)

0.47

 Pectus excavatum

1 (6.3)

0 (0.0)

0.49

  1. Data are shown as number (%) or mean ± SD
  2. Abbreviations: NTM Nontuberculous mycobacteria, BMI Body mass index, COPD Chronic obstructive pulmonary disease, HRCT High-resolution computed tomography
  3. aUnclassified: combined nodular-bronchiectatic + infiltrating shadow/ground glass opacity